Literature DB >> 24708078

Development and validation of the Overall Depression Severity and Impairment Scale.

Kate H Bentley1, Matthew W Gallagher2, Jenna R Carl1, David H Barlow1.   

Abstract

The need to capture severity and impairment of depressive symptomatology is widespread. Existing depression scales are lengthy and largely focus on individual symptoms rather than resulting impairment. The Overall Depression Severity and Impairment Scale (ODSIS) is a 5-item, continuous measure designed for use across heterogeneous mood disorders and with subthreshold depressive symptoms. This study examined the psychometric properties of the ODSIS in outpatients in a clinic for emotional disorders (N = 100), undergraduate students (N = 566), and community-based adults (N = 189). Internal consistency, latent structure, item response theory, classification accuracy, convergent and discriminant validity, and differential item functioning analyses were conducted. ODSIS scores exhibited excellent internal consistency, and confirmatory factor analyses supported a unidimensional structure. Item response theory results demonstrated that the ODSIS provides more information about individuals with high levels of depression than those with low levels of depression. Responses on the ODSIS discriminated well between individuals with and without a mood disorder and depression-related severity across clinical and subclinical levels. A cut score of 8 correctly classified 82% of outpatients as with or without a mood disorder; it evidenced a favorable balance of sensitivity and specificity and of positive and negative predictive values. The ODSIS demonstrated good convergent and discriminant validity, and results indicate that items function similarly across clinical and nonclinical samples. Overall, findings suggest that the ODSIS is a valid tool for measuring depression-related severity and impairment. The brevity and ease of use of the ODSIS support its utility for screening and monitoring treatment response across a variety of settings. PsycINFO Database Record (c) 2014 APA, all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24708078     DOI: 10.1037/a0036216

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  56 in total

1.  The moderating role of internalized homonegativity on the efficacy of LGB-affirmative psychotherapy: Results from a randomized controlled trial with young adult gay and bisexual men.

Authors:  Brett M Millar; Katie Wang; John E Pachankis
Journal:  J Consult Clin Psychol       Date:  2016-04-21

2.  The severity of psychiatric disorders.

Authors:  Mark Zimmerman; Theresa A Morgan; Kasey Stanton
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

3.  The critical role of internalized HIV-related stigma in the daily negative affective experiences of HIV-positive gay and bisexual men.

Authors:  H Jonathon Rendina; Brett M Millar; Jeffrey T Parsons
Journal:  J Affect Disord       Date:  2017-11-06       Impact factor: 4.839

4.  Countering emotional behaviors in the treatment of borderline personality disorder.

Authors:  Shannon Sauer-Zavala; Clair Cassiello-Robbins; Brittany K Woods; Andrew Curreri; Juilanne Wilner Tirpak; Madeleine Rassaby
Journal:  Personal Disord       Date:  2020-07-23

5.  A transdiagnostic minority stress intervention for gender diverse sexual minority women's depression, anxiety, and unhealthy alcohol use: A randomized controlled trial.

Authors:  John E Pachankis; Erin M McConocha; Kirsty A Clark; Katie Wang; Kriti Behari; Benjamin K Fetzner; Cal D Brisbin; Jillian R Scheer; Keren Lehavot
Journal:  J Consult Clin Psychol       Date:  2020-05-21

6.  Feasibility of an Emotion Regulation Intervention to Improve Mental Health and Reduce HIV Transmission Risk Behaviors for HIV-Positive Gay and Bisexual Men with Sexual Compulsivity.

Authors:  Jeffrey T Parsons; H Jonathon Rendina; Raymond L Moody; Sitaji Gurung; Tyrel J Starks; John E Pachankis
Journal:  AIDS Behav       Date:  2017-06

7.  A Preliminary Examination of the Effects of Transdiagnostic Versus Single Diagnosis Protocols on Anger During the Treatment of Anxiety Disorders.

Authors:  Clair Cassiello-Robbins; Shannon Sauer-Zavala; Julianne G Wilner; Kate H Bentley; Laren R Conklin; Todd J Farchione; David H Barlow
Journal:  J Nerv Ment Dis       Date:  2018-07       Impact factor: 2.254

8.  Pain intensity, e-cigarette dependence, and cessation-related outcomes: The moderating role of pain-related anxiety.

Authors:  Jessica M Powers; Lisa R LaRowe; Lorra Garey; Michael J Zvolensky; Joseph W Ditre
Journal:  Addict Behav       Date:  2020-07-11       Impact factor: 3.913

9.  Treating depressive disorders with the Unified Protocol: A preliminary randomized evaluation.

Authors:  Shannon Sauer-Zavala; Kate H Bentley; Stephanie Jarvi Steele; Julianne Wilner Tirpak; Amantia A Ametaj; Maya Nauphal; Nicole Cardona; Mengxing Wang; Todd J Farchione; David H Barlow
Journal:  J Affect Disord       Date:  2019-11-13       Impact factor: 4.839

10.  The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial.

Authors:  David H Barlow; Todd J Farchione; Jacqueline R Bullis; Matthew W Gallagher; Heather Murray-Latin; Shannon Sauer-Zavala; Kate H Bentley; Johanna Thompson-Hollands; Laren R Conklin; James F Boswell; Amantia Ametaj; Jenna R Carl; Hannah T Boettcher; Clair Cassiello-Robbins
Journal:  JAMA Psychiatry       Date:  2017-09-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.